<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <?properties manuscript?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-journal-id">0372772</journal-id>
      <journal-id journal-id-type="pubmed-jr-id">3705</journal-id>
      <journal-id journal-id-type="nlm-ta">Fertil Steril</journal-id>
      <journal-id journal-id-type="iso-abbrev">Fertil. Steril.</journal-id>
      <journal-title-group>
        <journal-title>Fertility and sterility</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0015-0282</issn>
      <issn pub-type="epub">1556-5653</issn>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">21570071</article-id>
      <article-id pub-id-type="pmc">5333557</article-id>
      <article-id pub-id-type="doi">10.1016/j.fertnstert.2011.04.056</article-id>
      <article-id pub-id-type="manuscript">NIHMS851508</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Magnetic resonance-guided focused ultrasound surgery for leiomyoma-associated infertility</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Bouwsma</surname>
            <given-names>Esther V. A.</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gorny</surname>
            <given-names>Krzysztof R.</given-names>
          </name>
          <degrees>Ph.D.</degrees>
          <xref ref-type="aff" rid="A2">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hesley</surname>
            <given-names>Gina K.</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A2">b</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jensen</surname>
            <given-names>Jani R.</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Peterson</surname>
            <given-names>Lisa G</given-names>
          </name>
          <degrees>R.N.</degrees>
          <xref ref-type="aff" rid="A1">a</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Stewart</surname>
            <given-names>Elizabeth A.</given-names>
          </name>
          <degrees>M.D.</degrees>
          <xref ref-type="aff" rid="A1">a</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>a</label>Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology</aff>
      <aff id="A2"><label>b</label>Department of Radiology, Mayo Clinic, Rochester, Minnesota</aff>
      <pub-date pub-type="nihms-submitted">
        <day>15</day>
        <month>2</month>
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>13</day>
        <month>5</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>7</month>
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>02</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <volume>96</volume>
      <issue>1</issue>
      <fpage>e9</fpage>
      <lpage>e12</lpage>
      <!--elocation-id from pubmed: 10.1016/j.fertnstert.2011.04.056-->
      <permissions>
        <license license-type="permissions-link" xlink:href="http://creativecommons.org/licenses/by/2.0/">
          <license-p>Reprint requests: Elizabeth A. Stewart, M.D., Professor of Obstetrics and Gynecology, Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Mayo Clinic and Mayo Medical School, 200 First Street, SW, Rochester, Minnesota 55901 (<email>stewart.elizabeth@mayo.edu</email>).</license-p>
        </license>
      </permissions>
      <abstract>
        <sec id="S1">
          <title>Objective</title>
          <p id="P1">To describe magnetic resonance-guided focused ultrasound surgery (FUS) as a treatment for a case of leiomyoma-associated infertility.</p>
        </sec>
        <sec id="S2">
          <title>Design</title>
          <p id="P2">Case report from a randomized clinical trial.</p>
        </sec>
        <sec id="S3">
          <title>Setting</title>
          <p id="P3">Academic medical center.</p>
        </sec>
        <sec id="S4">
          <title>Patient(s)</title>
          <p id="P4">A 37-year-old woman with known leiomyomas and a history of 18 months of home-inseminations from a known donor.</p>
        </sec>
        <sec id="S5">
          <title>Intervention(s)</title>
          <p id="P5">Magnetic resonance-guided FUS treatment of uterine fibroids, where the dominant fibroid distorted the uterine cavity.</p>
        </sec>
        <sec id="S6">
          <title>Main Outcome Measure(s)</title>
          <p id="P6">Pregnancy.</p>
        </sec>
        <sec id="S7">
          <title>Result(s)</title>
          <p id="P7">A viable intrauterine pregnancy, with a full-term vaginal delivery, was conceived after a single clomiphene citrate and intrauterine insemination cycle.</p>
        </sec>
        <sec id="S8">
          <title>Conclusion(s)</title>
          <p id="P8">The role of FUS for enhancement of fertility in women with nonhysteroscopically resectable uterine fibroids distorting the uterine cavity should be investigated further.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Fertility</kwd>
        <kwd>focused ultrasound</kwd>
        <kwd>FUS</kwd>
        <kwd>leiomyomas</kwd>
        <kwd>MRgFUS</kwd>
        <kwd>pregnancy</kwd>
        <kwd>randomized clinical trial</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p id="P9">Uterine leiomyomas are the most common tumors in women of reproductive age (<xref rid="R1" ref-type="bibr">1</xref>). The incidence of fibroids increases with age, and with the increased success of assisted reproductive technologies, more women of advanced maternal age are seeking pregnancies. Thus, the number of women seeking pregnancies and having leio-myomas is growing (<xref rid="R2" ref-type="bibr">2</xref>).</p>
    <p id="P10">The relationship between leiomyomas and fertility has been the subject of debate for many years (<xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R4" ref-type="bibr">4</xref>). However, there is now general consensus that the location of the fibroid and its relationship to the uterine cavity are the key factors in whether the fibroid has a negative influence on fertility (<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R6" ref-type="bibr">6</xref>). Submucosal fibroids are believed to decrease fertility rates the most, followed by intramural leiomyomas. Subserosal fibroids appear to have little to no effect on a woman's ability to conceive (<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R6" ref-type="bibr">6</xref>).</p>
    <p id="P11">For submucosal fibroids, it is agreed that myomectomy is beneficial and enhances the rates of fertility and live birth (<xref rid="R5" ref-type="bibr">5</xref>). However, for intramural fibroids there is not enough evidence to draw the same conclusions. It is not clear whether the difference in outcome is related to the biological differences between intramural and submucosal fibroids or to the fertility impairment from nonhysteroscopic surgeries for fibroids.</p>
    <p id="P12">We report a case from a randomized clinical trial (NCT00730886, <ext-link ext-link-type="uri" xlink:href="http://ClinicalTrials.gov">clinicaltrials.gov</ext-link>) evaluating fertility enhancement after magnetic resonance-guided focused ultrasound (FUS) or myomectomy in women with unexplained infertility, distortion of the uterine cavity, and nonhysteroscopically resectable uterine fibroids (type II submu-cosal and intramural). Focused ultrasound is a noninvasive therapy for treating uterine leiomyomas, and it was approved by the U.S. Food and Drug Administration (FDA) in 2004 for this indication. This technique converges multiple sound waves on a target site, causing localized coagulative necrosis, while guidance and thermal feedback are provided by magnetic-resonance imaging (MRI). Before conducting this trial, internal review board approval was obtained.</p>
    <sec id="S9">
      <title>Case Report</title>
      <p id="P13">A 37-year-old Asian female in a committed same-sex relationship presented for an infertility consultation. She had been attempting to conceive witha known sperm donor and had been using home insemination timed by ovulation predictor kits for 18 months. She had one spontaneous miscarriage at 6 weeks with this approach. Three weeks before her consultation at our institution, she had been diagnosed with uterine leiomyomas. She also reported leiomyoma symptoms, including heavy, prolonged menses and intermenstrual spotting.</p>
      <p id="P14">The patient underwent a basic infertility evaluation. An ultrasound examination showed several uterine fibroids and two hemorrhagic cysts in the right ovary, possibly consistent with endometriosis. A sonohysterography showed multiple fibroids with distortion of the uterine cavity, and an endometrial polyp was identified. Hysterosalpingogram showed normal opacification of both fallopian tubes and bilateral peritoneal spillage, and it confirmed the cavitary distortion. The ovaries appeared normal, with an antral follicle count of 18. Her cycle day-3 level of follicle-stimulating hormone (FSH) was 2.8 IU/L and of estradiol was 38 pg/mL. Her known sperm donor was a healthy 44-year-old male; his semen analysis was excellent, with a total motile sperm count of 141.8 million.</p>
      <p id="P15">An MRI with gadolinium was acquired to further evaluate the fibroids, revealing an enlarged uterus measuring 6.2 &#xD7; 9.4 &#xD7; 9.1 cm. Multiple myomas were identified, with a dominant fibroid measuring 4.8 &#xD7; 4.4 &#xD7; 5.1 cm in the inferior right lateral myometrial wall abutting the endometrium. An intramural fundal fibroid measured 3.5 &#xD7; 3.2 &#xD7; 3.0 cm, and three other 1-cm intramural fibroids were identified. Again, small hemorrhagic ovarian cysts, possibly consistent with endometriosis, were seen.</p>
      <p id="P16">The patient met the enrollment criteria for clinical trial NCT00730886; after we had obtained her written informed consent, she was randomized to the FUS arm. Treatment took place in two FUS sessions on two successive days without complications in August 2009. Only the dominant fibroid was treated in the first session, achieving a nonperfused volume (NPV) of 41%. In the second session, a NPV of 68% was achieved in the dominant fibroid, and four additional fibroids were ablated with similar results (<xref rid="F1" ref-type="fig">Fig. 1</xref>).</p>
      <p id="P17">During a subsequent visit in October 2009, a repeat sonohysterogram again showed a 7-mm polyp with no Doppler flow. A hysteroscopic polypectomy was performed, and the pathologic analysis confirmed a benign endometrial polyp.</p>
      <p id="P18">In November, the patient took 50 mg of clomiphene citrate for 5 days starting from cycle day 3. On cycle day 14, she detected a luteinizing hormone (LH) surge by use of an ovulation predictor kit. Intrauterine insemination (IUI) was performed the next day with cryopreserved donor sperm (postwash sperm count of 20.8 million). A home pregnancy test was subsequently positive.</p>
      <p id="P19">The patient was closely observed during her pregnancy with frequent ultrasounds. The placenta implanted on the anterior wall with no relation to the treatment sites (<xref rid="F2" ref-type="fig">Fig. 2</xref>). Fetal growth was normal, and the uterine fibroids remained stable in size. At 40 gestational weeks, the patient presented in labor with spontaneous rupture of membranes 24 hours before presentation. The patient had no fever and refused prophylactic antibiotics as recommended by her obstetric provider. After an uneventful labor, she gave birth to a 3,450 g girl, Apgar score of 7 and 9. Her postpartum course was complicated by a maternal temperature of 38.9&#xB0;C, and she was started on intravenous antibiotics for endomyometritis; she was discharged afebrile 2 days later. The baby was treated with phototherapy and intravenous immunoglobulin for hyperbilirubinemia due to ABO incompatibility.</p>
    </sec>
    <sec sec-type="discussion" id="S10">
      <title>Discussion</title>
      <p id="P20">Reproductive dysfunction is a rare symptom attributable to leiomyomas (<xref rid="R7" ref-type="bibr">7</xref>). Recently, Pritts et al. (<xref rid="R5" ref-type="bibr">5</xref>) conducted an updated sys-tematic review of fibroids and fertility, and concluded that the clinical pregnancy rate of women with any type of fibroid is statistically significantly lower than in control women (RR 0.85; 95% CI, 0.73&#x2013;0.98). However, in evaluating the effects on fertility by fibroid location, only submucosal and intramural fibroids have been found to have a negative influence on fertility. Moreover, for fibroids other than submucosal ones, surgical removal of the fibroids does not necessarily improve reproductive outcomes.</p>
      <p id="P21">There are two ways of interpreting this discrepancy. First, the fertility-impairing characteristics of submucosal fibroids may be more profound than those of intramural fibroids. Karyotypes of fibroids differ by location within the uterus, which suggests that there may be biological differences (<xref rid="R8" ref-type="bibr">8</xref>). An alternative explanation is that morbidity from the myomectomy accounts for the difference. Thus, hysteroscopic myomectomy may provide a net benefit for fertility while laparoscopic or abdominal myomectomy and their increased risk of bleeding, adhesion formation, and infection may not (<xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref>).</p>
      <p id="P22">A patient with unexplained infertility, endometrial cavity distortion, and a nonhysteroscopically resectable fibroid is a clinical dilemma. Our trial was designed to address this question by randomizing women with unexplained infertility to myomectomy or FUS.</p>
      <p id="P23">For patients who wish to conceive, FUS is a promising technique for treating leiomyomas. Since its introduction in 2004, there have been numerous reports documenting the safety and efficacy of FUS (<xref rid="R11" ref-type="bibr">11</xref>&#x2013;<xref rid="R18" ref-type="bibr">18</xref>). Moreover, a recent case series reported on the safety of pregnancies after FUS (<xref rid="R19" ref-type="bibr">19</xref>). Fifty-four pregnancies in 51 women that occurred after FUS treatment were prospectively registered with the FDA. Live births occurred in 41% of the pregnancies, with an additional 21% ongoing beyond 20 weeks. There was a 64% vaginal delivery rate, and the mean birth weight was 3.3 kg, with no low birth weight infants. It is interesting that, in over a third of the patients who conceived after FUS treatment, infertility was a complaint prior to treatment (<xref rid="R19" ref-type="bibr">19</xref>).</p>
      <p id="P24">In our patient, the distortion of the uterine cavity was not the only factor affecting her fertility. The patient also had undergone a hys-teroscopic procedure to remove a benign endometrial polyp. She elected to proceed with the clomiphene citrate plus intrauterine insemination treatment after that procedure, which most reviews suggest is an effective protocol for both unexplained and endometriosis-related infertility (<xref rid="R20" ref-type="bibr">20</xref>, <xref rid="R21" ref-type="bibr">21</xref>). Unfortunately, it is impossible to tell which aspect of her treatment contributed to her enhanced fertility. Because of the limited recruitment of participants, this randomized clinical trial was closed by the sponsor in February 2010. Only one other patient participated in the study, and she was also randomized to FUS. After her treatment, she underwent two IVF cycles but has yet to conceive.</p>
      <p id="P25">This case report shows that there may be a role for FUS for the enhancement of fertility in women with nonhysteroscopically re-sectable uterine fibroids and unexplained infertility. However, current experience is limited, and more systematic research is needed before any recommendations can be made.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="FN1">
        <p>E.V.A.B. has nothing to disclose. K.R.G. has nothing to disclose. G.K.H. received salary support through a clinical trial agreement between the Mayo Clinic and InSightec (Haifa, Israel) for clinical trial NCT00730886. J.R.J. has nothing to disclose. L.G.P. received salary support through a clinical trial agreement between the Mayo Clinic and InSightec (Haifa, Israel) for clinical trial NCT00730886. E.A.S. received salary support through a clinical trial agreement between the Mayo Clinic and InSightec (Haifa, Israel) for clinical trial NCT00730886, and also serves as a consultant to Abbott, Columbia Laboratories, and Gynesonics and serves on the Scientific Advisory Board for the Bayer HealthCare Scientific Committee.</p>
      </fn>
    </fn-group>
    <ref-list>
      <ref id="R1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Walker</surname>
              <given-names>CL</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Uterine fibroids: the elephant in the room</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>308</volume>
          <fpage>1589</fpage>
          <lpage>92</lpage>
          <pub-id pub-id-type="pmid">15947177</pub-id>
        </element-citation>
      </ref>
      <ref id="R2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klatsky</surname>
              <given-names>PC</given-names>
            </name>
            <name>
              <surname>Tran</surname>
              <given-names>ND</given-names>
            </name>
            <name>
              <surname>Caughey</surname>
              <given-names>AB</given-names>
            </name>
            <name>
              <surname>Fujimoto</surname>
              <given-names>VY</given-names>
            </name>
          </person-group>
          <article-title>Fibroids and reproductive outcomes: a systematic literature review from conception to delivery</article-title>
          <source>Am J Ob-stet Gynecol</source>
          <year>2008</year>
          <volume>198</volume>
          <fpage>357</fpage>
          <lpage>66</lpage>
        </element-citation>
      </ref>
      <ref id="R3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Donnez</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Jadoul</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>What are the implications of my-omas on fertility? A need for a debate?</article-title>
          <source>Hum Reprod</source>
          <year>2002</year>
          <volume>17</volume>
          <fpage>1424</fpage>
          <lpage>30</lpage>
          <pub-id pub-id-type="pmid">12042254</pub-id>
        </element-citation>
      </ref>
      <ref id="R4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pritts</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Fibroids and infertility: a systematic review of the evidence</article-title>
          <source>Obstet Gynecol Surv</source>
          <year>2001</year>
          <volume>56</volume>
          <fpage>483</fpage>
          <lpage>91</lpage>
          <pub-id pub-id-type="pmid">11496160</pub-id>
        </element-citation>
      </ref>
      <ref id="R5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pritts</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Parker</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Olive</surname>
              <given-names>DL</given-names>
            </name>
          </person-group>
          <article-title>Fibroids and infertility: an updated systematic review of the evidence</article-title>
          <source>Fertil Steril</source>
          <year>2009</year>
          <volume>91</volume>
          <fpage>1215</fpage>
          <lpage>23</lpage>
          <pub-id pub-id-type="pmid">18339376</pub-id>
        </element-citation>
      </ref>
      <ref id="R6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rackow</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Arici</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Fibroids and in-vitro fertilization: which comes first?</article-title>
          <source>Curr Opin Obstet Gynecol</source>
          <year>2005</year>
          <volume>17</volume>
          <fpage>225</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">15870554</pub-id>
        </element-citation>
      </ref>
      <ref id="R7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Uterine fibroids</article-title>
          <source>Lancet</source>
          <year>2001</year>
          <volume>357</volume>
          <fpage>293</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">11214143</pub-id>
        </element-citation>
      </ref>
      <ref id="R8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brosens</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Deprest</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Dal Cin</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Van den Berghe</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Clinical significance of cytogenetic abnormalities in uterine myomas</article-title>
          <source>Fertil Steril</source>
          <year>1998</year>
          <volume>69</volume>
          <fpage>232</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">9496334</pub-id>
        </element-citation>
      </ref>
      <ref id="R9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gehlbach</surname>
              <given-names>DL</given-names>
            </name>
            <name>
              <surname>Sousa</surname>
              <given-names>RC</given-names>
            </name>
            <name>
              <surname>Carpenter</surname>
              <given-names>SE</given-names>
            </name>
            <name>
              <surname>Rock</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Abdominal myomectomy in the treatment of infertility</article-title>
          <source>Int J Gynaecol Obstet</source>
          <year>1993</year>
          <volume>40</volume>
          <fpage>45</fpage>
          <lpage>50</lpage>
          <pub-id pub-id-type="pmid">8094350</pub-id>
        </element-citation>
      </ref>
      <ref id="R10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fauconnier</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dubuisson</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Ancel</surname>
              <given-names>PY</given-names>
            </name>
            <name>
              <surname>Chapron</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Prognostic factors of reproductive outcome after my-omectomy in infertile patients</article-title>
          <source>Hum Reprod</source>
          <year>2000</year>
          <volume>15</volume>
          <fpage>1751</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">10920098</pub-id>
        </element-citation>
      </ref>
      <ref id="R11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hesley</surname>
              <given-names>GK</given-names>
            </name>
            <name>
              <surname>Felmlee</surname>
              <given-names>JP</given-names>
            </name>
            <name>
              <surname>Gebhart</surname>
              <given-names>JB</given-names>
            </name>
            <name>
              <surname>Dunagan</surname>
              <given-names>KT</given-names>
            </name>
            <name>
              <surname>Gorny</surname>
              <given-names>KR</given-names>
            </name>
            <name>
              <surname>Kesler</surname>
              <given-names>JB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nonin-vasive treatment of uterine fibroids: early Mayo Clinic experience with magnetic resonance imaging-guided focused ultrasound</article-title>
          <source>Mayo Clin Proc</source>
          <year>2006</year>
          <volume>81</volume>
          <fpage>936</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="pmid">16835973</pub-id>
        </element-citation>
      </ref>
      <ref id="R12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fennessy</surname>
              <given-names>FM</given-names>
            </name>
            <name>
              <surname>Tempany</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>McDannold</surname>
              <given-names>NJ</given-names>
            </name>
            <name>
              <surname>So</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Hesley</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gostout</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Uterine leiomyomas: MR imaging-guided focused ultrasound surgery&#x2014;results of different treatment protocols</article-title>
          <source>Radiology</source>
          <year>2007</year>
          <volume>243</volume>
          <fpage>885</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">17446521</pub-id>
        </element-citation>
      </ref>
      <ref id="R13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stewart</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Gostout</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rabinovici</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Kim</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Regan</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Tempany</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Sustained relief of leiomyoma symptoms by using focused ultrasound surgery</article-title>
          <source>Obstet Gynecol</source>
          <year>2007</year>
          <volume>110</volume>
          <fpage>279</fpage>
          <lpage>87</lpage>
          <pub-id pub-id-type="pmid">17666601</pub-id>
        </element-citation>
      </ref>
      <ref id="R14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rabinovici</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Inbar</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Revel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Zalel</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Gomori</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Itzchak</surname>
              <given-names>Y</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical improvement and shrinkage of uterine fibroids after thermal ablation by magnetic resonance-guided focused ultrasound surgery</article-title>
          <source>Ultrasound Obstet Gynecol</source>
          <year>2007</year>
          <volume>30</volume>
          <fpage>771</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">17899577</pub-id>
        </element-citation>
      </ref>
      <ref id="R15">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morita</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hikida</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nakamura</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ohashi</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Non-invasive magnetic resonance imaging-guided focused ultrasound treatment for uterine fibroids&#x2014;early experience</article-title>
          <source>Eur J Obstet Gy-necol Reprod Biol</source>
          <year>2007</year>
          <volume>139</volume>
          <fpage>199</fpage>
          <lpage>203</lpage>
        </element-citation>
      </ref>
      <ref id="R16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morita</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Takeuchi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Hikida</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ohashi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Ito</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Decreasing margins to the uterine serosa as a method for increasing the volume of fibroids ablated with magnetic resonance-guided focused ultrasound surgery</article-title>
          <source>Eur J Obstet Gynecol Reprod Biol</source>
          <year>2009</year>
          <volume>146</volume>
          <fpage>92</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">19481328</pub-id>
        </element-citation>
      </ref>
      <ref id="R17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zaher</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Gedroyc</surname>
              <given-names>WM</given-names>
            </name>
            <name>
              <surname>Regan</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Patient suitability for magnetic resonance guided focused ultrasound surgery of uterine fibroids</article-title>
          <source>Eur J Obstet Gynecol Re-prod Biol</source>
          <year>2009</year>
          <volume>143</volume>
          <fpage>98</fpage>
          <lpage>102</lpage>
        </element-citation>
      </ref>
      <ref id="R18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Funaki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Fukunishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sawada</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-month follow-up</article-title>
          <source>Ultrasound Obstet Gynecol</source>
          <year>2009</year>
          <volume>34</volume>
          <fpage>584</fpage>
          <lpage>9</lpage>
          <pub-id pub-id-type="pmid">19852041</pub-id>
        </element-citation>
      </ref>
      <ref id="R19">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rabinovici</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>David</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Fukunishi</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Morita</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Gostout</surname>
              <given-names>BS</given-names>
            </name>
            <name>
              <surname>Stewart</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>Pregnancy outcome after magnetic resonance-guided focused ultrasound surgery (MRgFUS) for conservative treatment of uterine fibroids</article-title>
          <source>Fertil Steril</source>
          <year>2010</year>
          <volume>93</volume>
          <fpage>199</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="pmid">19013566</pub-id>
        </element-citation>
      </ref>
      <ref id="R20">
        <label>20</label>
        <element-citation publication-type="journal">
          <article-title>Use of clomiphene citrate in women</article-title>
          <source>Fertil Steril</source>
          <year>2006</year>
          <volume>86</volume>
          <issue>Suppl 1</issue>
          <fpage>S187</fpage>
          <lpage>93</lpage>
          <pub-id pub-id-type="pmid">17055820</pub-id>
        </element-citation>
      </ref>
      <ref id="R21">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hughes</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Vanderkerchove</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Clomiphene citrate for unexplained subfertility in women</article-title>
          <source>Cochrane Database Syst Rev</source>
          <year>2010</year>
          <volume>1</volume>
          <fpage>CD000057</fpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <p>(<bold>A&#x2013;B</bold>) Two fibroids (F1 and F2) on sagittal T2-weighted magnetic resonance imaging (MRI) before treatment. F1 is the dominant intramural fibroid in the right lateral myometrial wall abutting the endometrium. F2 is the smaller fundal fibroid. (<bold>C&#x2013;D</bold>) Posttreatment sagittal T1-weighted images demonstrating a large area of nonenhancement in both fibroids after the administration of gadolinium. The nonenhanced areas correspond to nonperfused tissues resulting from focused ultrasound surgery (FUS) ablation. These images show the largest dimensions of the fibroids and do not illustrate the cavitary distortion.</p>
      </caption>
      <graphic xlink:href="nihms851508f1"/>
    </fig>
    <fig id="F2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Transabdominal ultrasound image at 12 weeks' gestation showing the implantation of the placenta on the anterior wall. The treated dominant fibroid is located in the lateral myometrial wall and abuts the endometrial cavity.</p>
      </caption>
      <graphic xlink:href="nihms851508f2"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
